Hamamelis Water - Topical

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredient.

Notes

Date

April 13, 2010

Proper name(s)

Hamamelis virginiana L. (Hamamelidaceae) (USDA 1994)

Common name(s)

Source material(s) and Route(s) of administration

Twig (Bradley 2006; ESCOP 2003)

Dosage form(s)

Those pharmaceutical dosage forms suited to topical administration.

Use(s) or Purpose(s)

Statement(s) to the effect of:

Note: Claims for traditional use must include the term "Herbal Medicine".

Dose(s)

Subpopulation(s)

Adults, adolescents, and children ≥ 2 years (McIntyre 2005; Bove 2001; Schilcher 1997)

Quantity(ies):

Directions for use:

Notes:

Duration(s) of use

No statement required.

Risk information

Statement(s) to the effect of:

Caution(s) and warning(s)

Consult a health care practitioner if symptoms persist or worsen.

Contraindication(s)

No statement required.

Known adverse reaction(s)

In rare cases, some people may experience a (skin) rash (ESCOP 2003; Berardi et al. 2002; Mills and Bone 2000).

Non-medicinal ingredients

Must be chosen from the current NNHPD Natural Health Products Ingredients Database and must meet the limitations outlined in the database.

Specifications

Table 1: Monographs published in the British Pharmacopoeia (BP), European Pharmacopoeia (Ph. Eur.) and the U.S. Pharmacopeia (USP)
Pharmacopoeia Monograph
BP
Ph. Eur.
Hamamelis Leaf Monograph
USP Witch hazel Monograph

References cited

References reviewed

Appendix 1: Examples of appropriate dosage preparations, frequencies of use and directions for use

TOPICAL:

Twig: